GB202306756D0 - Antisense oligonucleotides for the treatment of cardiovascular disease - Google Patents

Antisense oligonucleotides for the treatment of cardiovascular disease

Info

Publication number
GB202306756D0
GB202306756D0 GBGB2306756.4A GB202306756A GB202306756D0 GB 202306756 D0 GB202306756 D0 GB 202306756D0 GB 202306756 A GB202306756 A GB 202306756A GB 202306756 D0 GB202306756 D0 GB 202306756D0
Authority
GB
United Kingdom
Prior art keywords
treatment
cardiovascular disease
antisense oligonucleotides
antisense
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2306756.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProQR Therapeutics II BV
Original Assignee
ProQR Therapeutics II BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProQR Therapeutics II BV filed Critical ProQR Therapeutics II BV
Priority to GBGB2306756.4A priority Critical patent/GB202306756D0/en
Publication of GB202306756D0 publication Critical patent/GB202306756D0/en
Pending legal-status Critical Current

Links

GBGB2306756.4A 2023-05-08 2023-05-08 Antisense oligonucleotides for the treatment of cardiovascular disease Pending GB202306756D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2306756.4A GB202306756D0 (en) 2023-05-08 2023-05-08 Antisense oligonucleotides for the treatment of cardiovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2306756.4A GB202306756D0 (en) 2023-05-08 2023-05-08 Antisense oligonucleotides for the treatment of cardiovascular disease

Publications (1)

Publication Number Publication Date
GB202306756D0 true GB202306756D0 (en) 2023-06-21

Family

ID=86763323

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2306756.4A Pending GB202306756D0 (en) 2023-05-08 2023-05-08 Antisense oligonucleotides for the treatment of cardiovascular disease

Country Status (1)

Country Link
GB (1) GB202306756D0 (en)

Similar Documents

Publication Publication Date Title
IL284363A (en) Rna-editing oligonucleotides for the treatment of usher syndrome
IL215682A0 (en) Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
SG11202109452SA (en) Compounds, compositions, and methods for the treatment of disease
EP4127174A4 (en) Antisense oligomers for treatment of disease
IL304679A (en) Antisense oligonucleotides increasing foxg1 expression
GB202306756D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202218585D0 (en) Antisense oligonucleotides for the treatment of cardiovascular disease
GB202306669D0 (en) Antisense oligonucleotides for the treatment of atherosclerotic cardiovascular disease
GB202302381D0 (en) Antisense oligonucleotides for the treatment of atherosclerotic cardiovascular disease
GB202318087D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202304438D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202316851D0 (en) Antisense oligonucleotides for the treatment of moyamoya disease
IL284417A (en) Antisense oligonucleotides for the treatment of leber's congenital amaurosis
GB202313645D0 (en) Antisense oligonucleotides for the treatment of metabolic disorders
ZA200704684B (en) Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease
GB202400404D0 (en) Antisense oligonucleotides for the treatment of polg-related disorders
GB202306060D0 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
GB202217580D0 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
GB202216844D0 (en) Antisense oligonucleotides for the treatment of bile acid related disorders
GB202218090D0 (en) Antisense oligonucleotides for the treatment of aldehyde dehydrogenase 2 deficiency
GB202309623D0 (en) Modified antisense oligonucleotides
GB202201798D0 (en) Modified antisense oligonucleotides
GB202302480D0 (en) shRNA for the treatment of disease
GB202319641D0 (en) Antisense oligonucleotides for the treatment of Huntingdon's Disease
GB202306581D0 (en) Treatment of cardiovascular disease